1. Adams, A., Strander, H., Cantell, K.: Sensitivity of the Epstein-Barr virus transformed human lymphoid cell lines to Interferon. J. gen. Virol.28, 207 (1975)
2. Aho, K., Strander, H., Leikola, J., Kleemola, M., Carlstr�m, G., Cantell, K.: An inhibitor of the complement-fixation reaction associated with interferon treatment. Clin. Immunol. Inmunopath.5, 399 (1976)
3. Anfinsen, C.B., Bose, S., Corley, L., Gurari-Rothman, D.: Partial purification of human interferon by affinity chromatography. Proc. Natl. Acad. Sci. (Am.)71, 3139 (1974)
4. Ankel, H., Besan�on, F.: Are gangliosides cell membrane receptors for interferon? Abstract, In: Symposium on interferons and the control of cell-virus interactions, Rehovot, Israel, May 2?6, 1977
5. Aparisi, T., Brostr�m, L.-�., Ingimarsson, S., Lagergren, C., Nilsonne, U., Strander, H., S�derberg, G.: Prognostic factors in osteosarcoma. Can historical controls be used in current clinical trials? Intern. J. Rad. Oncol. Biol. Phys. (in press) (1977)